2022
Vesical clear cell adenocarcinoma of Müllerian origin treated conservatively with partial cystectomy
Harold JA, Casilla-Lennon M, Kenney PA, Ratner ES. Vesical clear cell adenocarcinoma of Müllerian origin treated conservatively with partial cystectomy. BMJ Case Reports 2022, 15: e245015. PMID: 35383096, PMCID: PMC8984011, DOI: 10.1136/bcr-2021-245015.Peer-Reviewed Original ResearchMeSH KeywordsAdenocarcinoma, Clear CellAgedCystectomyFemaleHumansUrinary BladderUrinary Bladder DiseasesUrinary Bladder NeoplasmsConceptsClear cell adenocarcinomaPartial cystectomyCell adenocarcinomaMüllerian originPAX-8 stainingExtensive endometriosisAdjuvant therapyFinal pathologyTotal hysterectomyTransurethral resectionBladder massResidual tumorCystectomyAdenocarcinomaHysterectomyEndometriosisResectionTherapyTumorsPathologyWomen
2017
Financial Toxicity among Patients with Bladder Cancer: Reasons for Delay in Care and Effect on Quality of Life
Casilla-Lennon MM, Choi SK, Deal AM, Bensen JT, Narang G, Filippou P, McCormick B, Pruthi R, Wallen E, Tan HJ, Woods M, Nielsen M, Smith A. Financial Toxicity among Patients with Bladder Cancer: Reasons for Delay in Care and Effect on Quality of Life. Journal Of Urology 2017, 199: 1166-1173. PMID: 29155338, PMCID: PMC5947876, DOI: 10.1016/j.juro.2017.10.049.Peer-Reviewed Original ResearchMeSH KeywordsAgedCost of IllnessCross-Sectional StudiesFemaleHumansMaleQuality of LifeTime-to-TreatmentUrinary Bladder NeoplasmsConceptsQuality of lifeHealth Related QualityBladder cancerFinancial toxicityRelated qualitySpecific health related qualityCancer Survivorship CohortFisher's exact testStudent's t-testYounger patientsMedian ageMultivariable analysisSurvivorship cohortNoninvasive diseaseGeneral healthPatientsExact testMedical careCancerPoor healthMental healthCareTreatment costsSignificant predictorsFinancial burden